Researchers randomized patients with advanced neuroendocrine tumors 2:1 to receive either cabozantinib or placebo.
On January 29, 2025, the U.S. Court of Appeals for the Federal Circuit affirmed the grant of a preliminary injunction by the Northern District of ...
A research team has revealed that cadmium, a toxic heavy metal, increases the synthesis of hyaluronan in vascular endothelial ...
Maternal vitamin D status in early pregnancy is crucial for fetal growth and may reduce the risk of preterm birth, according ...
This research team evaluated the effectiveness of switching patients to faricimab treatment by assessing their outcomes after ...
Discover how integrating advanced imaging, digital pathology, and molecular analysis, can refine fibrosis staging and ...
Peptides have emerged as a fascinating class of biomolecules with multifaceted roles across biological systems. Vesugen, a ...